Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

Not yet recruiting

• Conditions: Hepatic Fibrosis

• Registration Number: NCT06715189
• Lead Sponsor: Sohag University

Brief Summary

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-11
• Study First Submitted: 2024-11-28
• Study First Submitted QC: 2024-11-28
• Last Update Submitted: 2024-11-28
• Study Start: 2024-12-01
• Study First Posted: 2024-12-04
• Last Update Posted: 2024-12-04
• Primary Completion: 2025-12-01
• Study Completion: 2025-12-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• patients of both sex who have type2 Diabetes Mellitus for less than five years

Exclusion Criteria

alcholics ,chronic liver disease elevated liver functions , sever infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
degree of hepatic fibrosis in MASLD with type 2 diabetes mellitus	1 year	adiponectineand resistine level with degree of hepatic fibrosis in MASLD pt. with type 2 DM